Chlamydia and coronary disease
Richer, G.
L'Union Medicale du Canada 118(3): 126-127
1989
ISSN/ISBN: 0041-6959 PMID: 2756607 Document Number: 346742
Document emailed within 1 workday
Related Documents
Imai, S.; Matsubara, T.; Hori, T.; Nakagawa, I.; Ozaki, K.; Hatada, K.; Mezaki, T.; Nasuno, A.; Kubota, K.; Tanaka, T.; Aizawa, Y. 2001: Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries Journal of Cardiology 37(6): 293-299Khasaev, A.S.; Gadzhieva, Z.G. 2003: Relationship between Chlamydia pneumoniae and classical risk factors of coronary heart disease Kardiologiia 43(10): 32-34
Leowattana, W.; Mahanonda, N.; Bhuripanyo, K.; Pokium, S.; Kiartivich, S. 2000: Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in Thailand Journal of the Medical Association of Thailand 83(9): 1054-1058
Leowattana, W.; Mahanonda, N.; Bhuripunyo, K.; Leelarasamee, A.; Pokum, S.; Suwimol, B. 1999: The prevalence of Chlamydia pneumoniae antibodies in Thai patients with coronary artery disease Journal of the Medical Association of Thailand 82(8): 792-797
Al-Ghamdi, A.; Jiman-Fatani, A.A.; El-Banna, H. 2011: Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease Pakistan Journal of Pharmaceutical Sciences 24(2): 95-101
Tauzeeh, S.M. 1997: Chlamydia pneumoniae infection and coronary heart disease. other infections might have role in South Asians Bmj 315(7121): 1539
Song, H.; Tasaki, H.; Yashiro, A.; Okazaki, M.; Ioka, T.; Taniguchi, H.; Nakashima, Y. 2001: Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure Clinical Nephrology 56(5): 346-352
Patel, P.; Mendall, M.A.; Carrington, D.; Strachan, D.P.; Leatham, E.; Molineaux, N.; Levy, J.; Blakeston, C.; Seymour, C.A.; Camm, A.J. 1995: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors BMJ 311(7007): 711-714
Márk, L.ás.ó; Márki-Zay, J.án.; Orosz, I.án.; Kondacs, A.ás.; Erdei, F.; Katona, A.ás. 2003: Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease Orvosi Hetilap 144(16): 765-768
Chaudhury, A.; Rajasekhar, D.; Latheef, S.A.A.; Subramanyam, G. 2003: Seropositivity of Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in a South Indian population Indian Heart Journal 55(4): 384
Leowattana, W.; Pokum, S.; Mahanonda, N.; Poungvarin, N. 2001: Rapid detection of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells of coronary artery disease patients by real-time fluorescence PCR Journal of the Medical Association of Thailand 84(Suppl 3): S658-S668
Ehgartner, E.M.; Faschinger, C.; Schuhmann, G.; Hanselmayer, H. 1988: Serumantikörper gegen Chlamydia trachomatis bei Patienten ohne chlamydien-spezifisches Krankheitsbild - Anticorps sériques contre Chlamydia trachomatis chez les malades sans symptôme spécifique de Chlamydiose - Antibodies against Chlamydia trachomatis in patients with chlamydia specific symptoms Deutschen Ophthalmologischen Gesellschaft (1985) 85(2): 206-209
Kuipers, J.G.; Andresen, J.; Köhler, L.; Schnarr, S.; Putschky, N.; Zeidler, H.; Wollenhaupt, J. 2002: Evaluation of amplicor chlamydia PCR and LCX chlamydia LCR to detect Chlamydia trachomatis in synovial fluid Clinical and Experimental Rheumatology 20(2): 185-192
Shafran, S.D.; Conley, J.M. 1997: Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Canadian Journal of Cardiology 13(11): 1017-1019
Yamagishi, I.; Abe, T.; Kuribayashi, R.; Sekine, S.; Seki, K.; Shibata, T. 1996: Coronary artery bypass grafting in a patient with severe coronary disease due to Kawasaki disease: a case report Kyobu Geka. Japanese Journal of Thoracic Surgery 49(2): 151-154
Carstens, V.; Haum, A.; Grond, M.; Behrenbeck, D.W. 1986: Incidence of coronary artery disease and necessity for coronary angiography in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 83-85
Gajek, J.; Choroszy-Król, I.; Zyśko, D.; Teryks-Wołyniec, D.; Halawa, B.ł 2003: The influence of Chlamydia pneumoniae infection on acute coronary syndromes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 20-23
Parada, M.T.; Kauffmann, R. 2000: Acute coronary syndrome associated with Chlamydia pneumoniae pneumonia in two cases Revista Medica de Chile 128(2): 201-205
Opherk, D.; Mäurer, W.; Mehmel, H.C.; Müller, J.H.; Zebe, H.; Kübler, W. 1976: Coronary circulation and myocardial O2 consumption in patients with coronary heart disease under isometric load and in maximal coronary dilatation Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1188-1190
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590